Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
25,583
Total Claims
$4.6M
Drug Cost
1,818
Beneficiaries
$2,549
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 6,382 Endocrinology providers
-35%
Cost per patient vs peers
$2,549 vs $3,933 avg
-29%
Brand preference vs peers
36.4% vs 51.2% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
0.1%
Opioid Rate
16
Opioid Claims
$181
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 9,092 claims · $4.2M
Generic: 15,884 claims · $363K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 1,188 | $808K |
| Empagliflozin | 448 | $346K |
| Levothyroxine Sodium | 2,998 | $302K |
| Empagliflozin/Metformin Hcl | 408 | $300K |
| Insulin Lispro | 338 | $248K |
| Insulin Lispro Protamin/Lispro | 244 | $212K |
| Dapaglifloz Propaned/Metformin | 250 | $205K |
| Dulaglutide | 178 | $202K |
| Insulin Nph Hum/Reg Insulin Hm | 400 | $173K |
| Insulin Glargine,hum.Rec.Anlog | 317 | $166K |
| Insulin Lispro Protamin/Lispro | 150 | $159K |
| Sitagliptin Phosphate | 182 | $158K |
| Empaglifloz/Linaglip/Metformin | 193 | $124K |
| Sitagliptin Phos/Metformin Hcl | 87 | $123K |
| Insulin Lispro | 90 | $79K |
Prescribing Profile
Patient Profile
72
Avg Age
73%
Female
1.99
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data